Form 8-K - Current report:
SEC Accession No. 0001522767-25-000010
Filing Date
2025-03-05
Accepted
2025-03-05 17:12:26
Documents
15
Period of Report
2025-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrmd-20250305.htm   iXBRL 8-K 24931
2 EX-99.1 ex991earningsreleaseq42024.htm EX-99.1 321421
6 picture2a.jpg GRAPHIC 8155
  Complete submission text file 0001522767-25-000010.txt   494527

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrmd-20250305.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrmd-20250305_lab.xml EX-101.LAB 20311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrmd-20250305_pre.xml EX-101.PRE 11505
17 EXTRACTED XBRL INSTANCE DOCUMENT mrmd-20250305_htm.xml XML 2512
Mailing Address 10 OCEANA WAY 2ND FLOOR NORWOOD MA 02062
Business Address 10 OCEANA WAY 2ND FLOOR NORWOOD MA 02062 781-277-0007
MARIMED INC. (Filer) CIK: 0001522767 (see all company filings)

EIN.: 274672745 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54433 | Film No.: 25712359
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)